AMERICAN INTERNATIONAL GROUP, INC. - CYMABAY THERAPEUTICS INC ownership

CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 194 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of CYMABAY THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$729,889
+41.2%
48,953
+3.7%
0.01%
+66.7%
Q2 2023$516,982
+294.6%
47,213
+11.7%
0.00%
+200.0%
Q1 2022$131,000
+5.6%
42,257
+14.7%
0.00%0.0%
Q4 2021$124,000
-10.1%
36,834
-2.9%
0.00%0.0%
Q3 2021$138,000
-18.3%
37,936
-2.3%
0.00%0.0%
Q2 2021$169,000
-7.7%
38,837
-3.8%
0.00%0.0%
Q1 2021$183,000
-20.8%
40,372
+0.3%
0.00%0.0%
Q4 2020$231,000
-23.0%
40,265
-2.8%
0.00%0.0%
Q3 2020$300,000
+102.7%
41,420
-2.2%
0.00%0.0%
Q2 2020$148,000
+146.7%
42,362
+3.9%
0.00%
Q1 2020$60,000
-29.4%
40,777
-5.5%
0.00%
Q4 2019$85,000
-61.9%
43,133
-0.8%
0.00%
-100.0%
Q3 2019$223,000
-29.0%
43,497
-0.7%
0.00%0.0%
Q2 2019$314,000
-37.8%
43,799
+15.2%
0.00%
-50.0%
Q1 2019$505,000
+65.6%
38,005
-2.0%
0.00%
+100.0%
Q4 2018$305,000
-29.6%
38,794
-0.8%
0.00%0.0%
Q3 2018$433,000
-15.9%
39,093
+1.8%
0.00%
-50.0%
Q2 2018$515,00038,3890.00%
Other shareholders
CYMABAY THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 1,653,495$10,367,4148.97%
Versant Venture Management, LLC 543,753$3,409,3307.06%
TCG Crossover Management, LLC 5,905,400$37,026,8586.54%
COMMODORE CAPITAL LP 5,738,500$35,9805.42%
Foresite Capital Management IV, LLC 1,787,094$11,205,0794.79%
Saturn V Capital Management LP 1,611,778$5,718,4324.74%
ACUTA CAPITAL PARTNERS, LLC 1,015,000$6,364,0503.92%
Altium Capital Management LP 1,025,000$6,426,7503.27%
Affinity Asset Advisors, LLC 1,143,531$7,169,9392.81%
GREAT POINT PARTNERS LLC 1,550,000$9,718,5001.90%
View complete list of CYMABAY THERAPEUTICS INC shareholders